FDA interested in details of industry OTC anticaries biological testing plan -- Bowen.
This article was originally published in The Tan Sheet
Executive Summary
FDA INTERESTED IN DETAILED INDUSTRY PLAN FOR ANTICARIES BIOLOGICAL TESTING as the agency considers industry's request to postpone the Oct. 7 effective date of the anticaries final monograph by one year. OTC Division Director Debra Bowen expressed interest in the information at an April 3 OTC "feedback" meeting with the oral care task force, formed jointly by the Nonprescription Drug Manufacturers Association and the Cosmetic, Toiletry and Fragrance Association.